Related Articles
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway Corrigendum in /10.3892/or.2023.8602
CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma
Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells
Didymin reverses phthalate ester-associated breast cancer aggravation in the breast cancer tumor microenvironment